REQUEST A DEMO
Total
USD $0.00
Search more companies

Binex Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Binex Co.,Ltd. Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Binex Co., Ltd. is engaged in manufacturing and distribution of pharmaceutical products. The company's product portfolio includes Bisroot products, GI tract & Antispasmodic & Anti-ulcer agent, NSAIDs, Cardiovascular & urology, Hepatic protectors, Ointment & Creams, Ophthalmic solution, CNS agent. Binex's products are used as Digestive prescription drug, Constipation & Blood circulation prescription drug, Antibiotic & Antifungal agent, Cough & Cold remedies, Vitamins & Nutrients, Antihistamine, Anti-vertigo and OTC. The company manages Korea Biotechnology commercialization Center (KBCC). Binex Co., Ltd.'s headquarters and R&D center is located in Busan, South Korea. The company was founded in 1957 formerly known as SoonCheonDang.

Headquarters
368-3, Dadae-Ro, Saha-Gu
Busan; Busan; Postal Code: 604-846

Contact Details: Purchase the Binex Co.,Ltd. report to view the information.

Website: http://www.bi-nex.co.kr

Basic Information
Total Employees:
Purchase the Binex Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Binex Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Binex Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Binex Co.,Ltd. report to view the information.
Incorporation Date:
June 05, 1985
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
12.61%
Purchase this report to view the information.
5.61%
Purchase this report to view the information.
0.13%
Subsidiaries
Pepromene Bio Inc
8.8%
Binex Co.,Ltd.
5.61%
Trigr Therapeutics Inc
1.91%
Company Performance
Financial values in the chart are available after Binex Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.57%
Total operating revenue
5.63%
Operating profit (EBIT)
-60.06%
EBITDA
-39.53%
Net Profit (Loss) for the Period
-77.05%
Total assets
-3.4%
Total equity
-3.47%
Operating Profit Margin (ROS)
-8.99%
Net Profit Margin
-8.42%
Return on Equity (ROE)
-4.96%
Debt to Equity Ratio
4.33%
Quick Ratio
-0.15%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?